CBA Institutional have been covering GBT for a couple of years and while they still have GBT on their coverage list no update was released following the interim results. I also notice no update has been released for IRE. Has the particular analyst left CBA or could research be suspended due to corporate work? I note CBA is GBT's lender so it is logical that they might also be their corporate adviser. Anyway a bit of wild speculation on my part
GBT Price at posting:
$5.39 Sentiment: None Disclosure: Held